ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

25 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference

11 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

28 мар 2024 16:01:21 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

20 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

14 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

06 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission

29 фев 2024 08:01:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

29 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

11 дек 2023 16:30:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update

09 ноя 2023 16:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023

26 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

03 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting

11 сен 2023 08:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

07 сен 2023 08:00:01 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update

14 авг 2023 16:00:00 Источник Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast

01 авг 2023 08:00:01 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting

18 июл 2023 08:00:01 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)

11 июл 2023 11:23:26 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

06 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire

Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering

25 май 2023 09:00:00 Источник Nasdaq GlobeNewswire